Regulatory Update #262

23 November 2017

Dr Chris Parker appointed as APVMA Chief Executive Officer

Dr Chris Parker was appointed to the permanent position of Chief Executive Officer (CEO) of the APVMA on Wednesday 15 November 2017.

Dr Parker has provided valuable leadership to the agency as our interim CEO since June 2017. The Assistant Minister for Agriculture and Water Resources, Luke Hartsukyer, announced Dr Parker’s five year appointment in a statement available from the Assistant Minister’s website.

Read more

TGA to adopt new PIC/S Guide to Good Manufacturing Practice—will you be impacted?

From 1 January 2018 the Therapeutic Goods Administration (TGA) will be adopting the latest version of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guide to Good Manufacturing Practice.

Veterinary chemical product manufacturers registered with the APVMA who have their audits completed by the TGA will need to comply with the latest version of the Guide.

All affected manufacturers are encouraged to review the information published by the TGA on their website

Read more

Strengthening ties and advancing innovation in global regulatory science

Our recent Chief Scientist blog summarises how domestic and international collaboration with counterpart regulatory bodies helps to advance our work and build scientific harmonisation.

These themes were discussed during the Chief Scientist's recent participation at the annual Global Summit on Regulatory Science (GSRS2017) in Brasilia, Brazil. Building industry relationships and exploring innovative technologies are important in streamlining and maintaining the quality of our regulatory work.

Read more

APVMA collaborating with international counterparts at outreach forum in Tokyo

Last week our CEO, Dr Chris Parker attended the 35th VICH steering committee meeting in Tokyo, Japan. Our attendance at these meetings was as an observer member of VICH, contributing to discussions and promoting coordination between national regulatory agencies.

Dr Parker also took part in the VICH Outreach Forum–an international initiative to harmonise technical requirements and improve information exchange for veterinary medicines. Our participation in forums like VICH is one example of how the APVMA is working to streamline and harmonise regulatory requirements across jurisdictions. Read more about our collaborations with overseas regulators and the work we undertake on joint reviews and assessments.

Read more

Reminder—open for public consultation

We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:

Contact us

Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604

Add us to your address book

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.